{"version":"1.0","type":"link","title":"Talazoparib Formulation Bridging in Cancer Patients-Challenges and the Critical Role of Model-Informed Drug Development in Approval Despite Failed Bioequivalence.","author_name":"Wang D 외","author_url":"https://prs-insight.online/author/Wang%20D","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/133252","thumbnail_width":1200,"thumbnail_height":630}